|
2025
|
Invention
|
Method for the qualificaiton of an industrial aseptic distribution line and associated simulation... |
|
|
Invention
|
Anti-fibrinogen aptamers.
The invention relates to a new method for obtaining aptamers directed ... |
|
2024
|
Invention
|
Fc polypeptide variants having an increased half-life.
Disclosed is a variant of a parent polype... |
|
|
P/S
|
Transport and storage of goods; transport, distribution
(delivery) and storage of human blood pl... |
|
|
Invention
|
Anti-cd20 antibody compositions.
Provided herein are populations of anti-CD20 antibody proteins ... |
|
|
P/S
|
Transport of goods and Storage of goods; Transport, Delivery and Storage in relation to the follo... |
|
2023
|
P/S
|
Recombinant monoclonal antibodies for medical use directed
against CD 20 (B lymphocyte surface p... |
|
|
P/S
|
Recombinant monoclonal antibodies for medical use directed
against CD 20 (B-cell surface protein). |
|
|
P/S
|
Providing access to platforms and portals on the Internet Computer hardware; downloadable and rec... |
|
|
P/S
|
Computer hardware; computer software; platform software. Providing access to platforms and portal... |
|
|
P/S
|
Anti-CD20 recombinant monoclonal antibody for medical use |
|
|
P/S
|
Anti-CD20 recombinant monoclonal antibody for medical use. |
|
|
P/S
|
Telecommunication services relating to the provision of medical information in the field of immun... |
|
|
Invention
|
Commercial-scale recombinant protein production in rat hybridoma cells. The present disclosure re... |
|
|
Invention
|
Fc mutants with modified functional activity.
Disclosed is a polypeptide including a mutated Fc ... |
|
|
Invention
|
Anti-cd20 antibody compositions. Provided herein are populations of anti-CD20 antibody proteins w... |
|
2022
|
P/S
|
Pharmaceutical products; medicine; injectable pharmaceutical
preparations; therapeutic proteins ... |
|
|
P/S
|
Pharmaceutical products used for the prevention, treatment and control of bleeding episodes; medi... |
|
|
P/S
|
Pharmaceutical products and preparations for the prevention, treatment and control of bleeding ep... |
|
|
P/S
|
Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of ... |
|
|
P/S
|
Pharmaceutical preparations, medicines, injectable
pharmaceutical preparations, therapeutic prot... |
|
|
P/S
|
Pharmaceutical products; medicine; injectable pharmaceutical preparations; therapeutic proteins f... |
|
2021
|
Invention
|
Novel human erythroid progenitor cell line highly permissive to b19 infection and uses thereof.
... |
|
|
Invention
|
Novel human erythroid progenitor cell line highly permissive to b19 infection and uses thereof. T... |
|
|
Invention
|
Triple combination to treat b-cell malignancies. A triple combination of agents comprising: (i) a... |
|
|
Invention
|
Triple combination to treat b-cell malignancies.
Methods for treating B-cell malignancies are pr... |
|
|
P/S
|
Pharmaceuticals, Medicine, Injectable pharmaceuticals, Therapeutic proteins, All the aforesaid go... |
|
|
Invention
|
Anti-fibrinogen aptamers. The invention relates to a new method for obtaining aptamers directed a... |
|
|
P/S
|
Medical services, namely, blood component collection services |
|
|
P/S
|
Pharmaceuticals, Medicine, Injectable pharmaceutical preparations, therapeutic proteins for use i... |
|
2020
|
Invention
|
Human monocyte cell line and use of same as a cell model of phagocytosis. The present invention c... |
|
|
Invention
|
Combination of anti-cd20 antibody and pi3 kinase selective inhibitor.
Highly effective combinati... |
|
|
Invention
|
Factor vii composition having a substantially homogeneous isoelectric point.
The present inventi... |
|
|
Invention
|
Factor vii composition having a substantially homogenous isoelectric point. The present invention... |
|
|
Invention
|
Anti-cd303 monoclonal antibodies.
The invention relates to chimeric or humanised anti-CD303 anti... |
|
|
P/S
|
Advertising relating thereto. |
|
2019
|
Invention
|
Method for filtering fibrinogen.
Disclosed is a method for filtering a fibrinogen composition, c... |
|
|
Invention
|
Method for filtering fibrinogen. Disclosed is a method for filtering a fibrinogen composition, co... |
|
|
Invention
|
Sampling device for sampling from a surface of an industrial vessel without requiring a person to... |
|
|
Invention
|
Oral composition of anti-tnf alpha antibodies.
The present invention relates to a pharmaceutica... |
|
|
Invention
|
Method of preserving cells for therapeutic use.
Disclosed is a composition including, in a physi... |
|
|
Invention
|
Method of preserving cells for therapeutic use. The invention relates to a composition comprising... |
|
|
Invention
|
Novel use of von willebrand factor.
The present invention relates to a von Willebrand factor com... |
|
|
Invention
|
Methods of purifying antibodies from the milk of transgenic non-human mammals comprising the use ... |
|
|
P/S
|
Program (software) for training in the management of
dysimmune neuropathies, particularly periph... |
|
|
Invention
|
Conditions for storing a protein composition comprising surfactant and change in the surfactant c... |
|
|
Invention
|
Combination of factor vii and an anti-factor ix/x bispecific antibody.
The invention concerns a ... |
|
|
Invention
|
Combination of factor vii and an anti-factor ix/x bispecific antibody. The invention relates to a... |
|
|
Invention
|
Antibodies with increased activity in the digestive tract. The present invention concerns antibod... |
|
|
Invention
|
Use of monoclonal antibodies for the treatment of inflammation and bacterial infections.
A compo... |
|
|
Invention
|
Composition of concentrated human immunoglobulins.
The invention proposes the use of a pharmaceu... |
|
|
Invention
|
Composition of concentrated human immunoglobulins. The invention relates to the use of a pharmace... |
|
|
Invention
|
Highly sialylated autoantibodies and uses thereof. The present invention relates to a G-isotype a... |
|
2018
|
Invention
|
Method for purifying antibodies from raw milk.
The present application relates to a method for p... |
|
|
Invention
|
Variants with fc fragment having an increased affinity for fcrn and an increased affinity for at ... |
|
|
Invention
|
Method for the cryopreservation of cells for therapeutic purposes. e) cells for therapeutic purpo... |
|
|
Invention
|
Specific binding molecule directed against galectin-3 protein. A specific binding molecule is pro... |
|
|
Invention
|
Antibodies targeting a ligand from an immune checkpoint, with an fc fragment having an improved a... |
|
2017
|
Invention
|
Liquid human fibrinogen composition.
The invention relates to a pharmaceutical composition compr... |
|
|
Invention
|
Combination of ant-cd303 and anti-amhrii antibodies.
Disclosed is a pharmaceutical composition i... |
|
|
Invention
|
Combination of anti-cd303 and anti-her2 antibodies.
Disclosed is a pharmaceutical composition in... |
|
|
Invention
|
Method for the virus inactivation of a preparation of monoclonal antibodies.
The present inventi... |
|
|
P/S
|
Pharmaceutical and veterinary products and preparations for the treatment of disorders or disease... |
|
|
P/S
|
Pharmaceutical and veterinary products and preparations;
medicines; diagnostic products for medi... |
|
|
P/S
|
Pharmaceutical products for treating inflammatory diseases
of the digestive tract. |
|
|
P/S
|
Scientific and technological services, namely, laboratory research relating to the design of new ... |
|
|
P/S
|
Scientific and technological services as well as research
and design services relating thereto i... |
|
|
Invention
|
Factor x variants.
Disclosed is a protein that is a factor X variant including a mutated sequenc... |
|
2016
|
Invention
|
Factor h fragment for use as an anti-angiogenic agent.
The invention relates to a complement fac... |
|
|
P/S
|
Medical and veterinary preparations and articles; Pharmaceuticals and natural remedies; Anti-infe... |
|
|
P/S
|
Pharmaceutical products and preparations; medicines;
therapeutic proteins; monoclonal antibodies... |
|
|
P/S
|
Pharmaceutical products for the treatment of melanoma. |
|
|
P/S
|
Computer software for training and informing health
professionals and patients in the field of i... |
|
2014
|
P/S
|
Pharmaceutical products and preparations; blood proteins
naturally occurring or of transgenic, s... |
|
|
P/S
|
Pharmaceutical preparations, medicines, injectable pharmaceutical preparations, therapeutic prote... |
|
|
P/S
|
Pharmaceutical products; injectable pharmaceutical products;
immunoglobulins; injectable immunog... |
|
|
P/S
|
Custom manufacture of pharmaceuticals, biosimilars, biopharmaceutical and veterinary preparations... |
|
|
P/S
|
Pharmaceutical, [ biosimilar,] biopharmaceutical, [ and veterinary] preparations for the treatmen... |
|
2013
|
P/S
|
Medicines and pharmaceutical preparations obtained by means
of a purification process using apta... |
|
2012
|
P/S
|
Pharmaceutical preparations, medicines, injectable
pharmaceutical preparations, therapeutic plas... |
|
|
P/S
|
Pharmaceutical products, medicines, injectable
pharmaceutical preparations, therapeutic proteins... |
|
|
P/S
|
Plasma-derived clotting factor concentrates. |
|
|
P/S
|
Pharmaceutical preparations. |
